Bios Fund III Qp, LP
CIK 0001791916
Director10% Owner
Filings
13
Latest Jun 30, 2025
Issuers covered
4
Showing
13 of 13
Page 1
Track record
18 of 18 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 18 | 56% | +0.8% | +12.5% | +16.7% | -16.7% |
| 90 days | 18 | 56% | -9.6% | +1.4% | +63.1% | -63.1% |
| 180 days | 18 | 56% | -10.9% | +4.4% | +74.7% | -74.7% |
| 365 days | 17 | 53% | -14.7% | +10.2% | +97.1% | -97.1% |
Issuers
Companies where Bios Fund III Qp, LP has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CGTX | Cognition Therapeutics Inc | 5 | Jun 20, 2025 |
| ACTU | Actuate Therapeutics, Inc. | 4 | Jun 30, 2025 |
| INAB | In8bio, Inc. | 3 | May 7, 2025 |
| AZTR | Azitra Inc | 1 | Jun 23, 2023 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|